CRF-1 Antagonist and CRF-2 Agonist Decrease Binge-Like Ethanol Drinking in C57BL/6J Mice Independent of the HPA Axis (original) (raw)

• Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB (1999). The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160: 1–12.
  Article CAS PubMed Google Scholar
• Battaglia G, Webster EL, De Souza EB (1987). Characterization of corticotropin-releasing factor receptor-mediated adenylate cyclase activity in the rat central nervous system. Synapse 1: 572–581.
  Article CAS PubMed Google Scholar
• Bonomo YA, Bowes G, Coffey C, Carlin JB, Patton GC (2004). Teenage drinking and the onset of alcohol dependence: a cohort study over seven years. Addiction (Abingdon, England) 99: 1520–1528.
  Article Google Scholar
• Brauns O, Liepold T, Radulovic J, Spiess J (2001). Pharmacological and chemical properties of astressin, antisauvagine-30 and alpha-helCRF: significance for behavioral experiments. Neuropharmacology 41: 507–516.
  Article CAS PubMed Google Scholar
• Centers for Disease Control and Prevention (CDC) (2009). Sociodemographic differences in binge drinking among adults—14 States, 2004. MMWR Surveill Summ 58: 301–304.
  Google Scholar
• Chen YL, Mansbach RS, Winter SM, Brooks E, Collins J, Corman ML et al (1997). Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonist. J Med Chem 40: 1749–1754.
  Article CAS PubMed Google Scholar
• Ciccocioppo R, Economidou D, Cippitelli A, Cucculelli M, Ubaldi M, Soverchia L et al (2006). Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism. Addict Biol 11: 339–355.
  Article PubMed PubMed Central Google Scholar
• Courtney KE, Polich J (2009). Binge drinking in young adults: data, definitions, and determinants. Psychol Bull 135: 142–156.
  Article PubMed PubMed Central Google Scholar
• D'Anna KL, Stevenson SA, Gammie SC (2005). Urocortin 1 and 3 impair maternal defense behavior in mice. Behav Neurosci 119: 1061–1071.
  Article PubMed Google Scholar
• Eaton DK, Kann L, Kinchen S, Shanklin S, Ross J, Hawkins J et al (2008). Youth risk behavior surveillance—United States, 2007. MMWR Surveill Summ 57: 1–131.
  PubMed Google Scholar
• Fahlke C, Hard E, Eriksson CJ, Engel JA, Hansen S (1995). Consequence of long-term exposure to corticosterone or dexamethasone on ethanol consumption in the adrenalectomized rat, and the effect of type I and type II corticosteroid receptor antagonists. Psychopharmacology (Berl) 117: 216–224.
  Article CAS Google Scholar
• Fahlke C, Hard E, Hansen S (1996). Facilitation of ethanol consumption by intracerebroventricular infusions of corticosterone. Psychopharmacology (Berl) 127: 133–139.
  Article CAS Google Scholar
• Fahlke C, Hard E, Thomasson R, Engel JA, Hansen S (1994). Metyrapone-induced suppression of corticosterone synthesis reduces ethanol consumption in high-preferring rats. Pharmacol Biochem Behav 48: 977–981.
  Article CAS PubMed Google Scholar
• Finn DA, Snelling C, Fretwell AM, Tanchuck MA, Underwood L, Cole M et al (2007). Increased drinking during withdrawal from intermittent ethanol exposure is blocked by the CRF receptor antagonist d-Phe-CRF(12–41). Alcohol Clin Exp Res 31: 939–949.
  Article CAS PubMed Google Scholar
• Funk CK, O'Dell LE, Crawford EF, Koob GF (2006). Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci 26: 11324–11332.
  Article CAS PubMed PubMed Central Google Scholar
• Goeders NE, Guerin GF (1996). Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self-administration in rats. Brain Res 722: 145–152.
  Article CAS PubMed Google Scholar
• Goeders NE, Guerin GF (2008). Effects of the combination of metyrapone and oxazepam on cocaine and food self-administration in rats. Pharmacol Biochem Behav 91: 181–189.
  Article CAS PubMed PubMed Central Google Scholar
• Gupta T, Syed YM, Revis AA, Miller SA, Martinez M, Cohn KA et al (2008). Acute effects of acamprosate and MPEP on ethanol drinking-in-the-dark in male C57BL/6J mice. Alcohol Clin Exp Res 32: 1992–1998.
  CAS PubMed Google Scholar
• Hauger RL, Risbrough V, Brauns O, Dautzenberg FM (2006). Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets 5: 453–479.
  Article CAS PubMed PubMed Central Google Scholar
• Heikinheimo O, Pesonen U, Huupponen R, Koulu M, Lahteenmaki P (1994). Hepatic metabolism and distribution of mifepristone and its metabolites in rats. Hum Reprod (Oxford, England) 9 (Suppl 1): 40–46.
  Article CAS Google Scholar
• Heilig M, Koob GF (2007). A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 30: 399–406.
  Article CAS PubMed PubMed Central Google Scholar
• Heinrichs SC, Koob GF (2004). Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation. J Pharmacol Exp Ther 311: 427–440.
  Article CAS PubMed Google Scholar
• Heinrichs SC, Menzaghi F, Pich EM, Baldwin HA, Rassnick S, Britton KT et al (1994). Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity. Neuropsychopharmacology 11: 179–186.
  Article CAS PubMed Google Scholar
• Heinrichs SC, Richard D (1999). The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior. Neuropeptides 33: 350–359.
  Article CAS PubMed Google Scholar
• Hendrickson LM, Zhao-Shea R, Tapper AR (2009). Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice. Psychopharmacology (Berl) 204: 563–572.
  Article CAS Google Scholar
• Imaki T, Naruse M, Harada S, Chikada N, Imaki J, Onodera H et al (1996). Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus. Brain Res Mol Brain Res 38: 166–170.
  Article CAS PubMed Google Scholar
• Jennison KM (2004). The short-term effects and unintended long-term consequences of binge drinking in college: a 10-year follow-up study. Am J Drug Alcohol Abuse 30: 659–684.
  Article PubMed Google Scholar
• Ji D, Gilpin NW, Richardson HN, Rivier CL, Koob GF (2008). Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats. Behav Pharmacol 19: 1–12.
  Article PubMed PubMed Central Google Scholar
• Jonas HA, Dobson AJ, Brown WJ (2000). Patterns of alcohol consumption in young Australian women: socio-demographic factors, health-related behaviours and physical health. Aust N Z J Public Health 24: 185–191.
  Article CAS PubMed Google Scholar
• Kamdar NK, Miller SA, Syed YM, Bhayana R, Gupta T, Rhodes JS (2007). Acute effects of naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL/6J mice. Psychopharmacology (Berl) 192: 207–217.
  Article CAS Google Scholar
• Kehne JH (2007). The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders. CNS Neurol Disord Drug Targets 6: 163–182.
  Article CAS PubMed Google Scholar
• Keller C, Bruelisauer A, Lemaire M, Enz A (2002). Brain pharmacokinetics of a nonpeptidic corticotropin-releasing factor receptor antagonist. Drug Metab Dispos 30: 173–176.
  Article CAS PubMed Google Scholar
• Keyes KM, Grant BF, Hasin DS (2008). Evidence for a closing gender gap in alcohol use, abuse, and dependence in the United States population. Drug Alcohol Depend 93: 21–29.
  Article PubMed Google Scholar
• Koenig HN, Olive MF (2004). The glucocorticoid receptor antagonist mifepristone reduces ethanol intake in rats under limited access conditions. Psychoneuroendocrinology 29: 999–1003.
  Article CAS PubMed Google Scholar
• Koob G, Kreek MJ (2007). Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164: 1149–1159.
  Article PubMed PubMed Central Google Scholar
• Koob GF (2000). Animal models of craving for ethanol. Addiction (Abingdon, England) 95 (Suppl 2): S73–S81.
  Article Google Scholar
• Koob GF (2003). Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 27: 232–243.
  Article CAS PubMed Google Scholar
• Koob GF (2008). A role for brain stress systems in addiction. Neuron 59: 11–34.
  Article CAS PubMed PubMed Central Google Scholar
• Koob GF, Le Moal M (2008). Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond 363: 3113–3123.
  Article Google Scholar
• Krishnan S, Nash Jr JF, Maickel RP (1991). Free-choice ethanol consumption by rats: effects of ACTH4-10. Alcohol (Fayetteville, NY) 8: 401–404.
  Article CAS Google Scholar
• Krugers HJ, Maslam S, Korf J, Joels M, Holsboer F (2000). The corticosterone synthesis inhibitor metyrapone prevents hypoxia/ischemia-induced loss of synaptic function in the rat hippocampus. Stroke 31: 1162–1172.
  Article CAS PubMed Google Scholar
• Kuperman Y, Chen A (2008). Urocortins: emerging metabolic and energy homeostasis perspectives. Trends Endocrinol Metab 19: 122–129.
  Article CAS PubMed Google Scholar
• Laborie C, Bernet F, Dutriez-Casteloot I, Lesage J, Dupouy JP (1997). Effect of cholinergic blockade on glucocorticoid regulation of NPY and catecholamines in the rat adrenal gland. Neuroendocrinology 66: 98–105.
  Article CAS PubMed Google Scholar
• Laborie C, Bernet F, Kerckaert JP, Maubert E, Lesage J, Dupouy JP (1995). Regulation of neuropeptide Y and its mRNA by glucocorticoids in the rat adrenal gland. Neuroendocrinology 62: 601–610.
  Article CAS PubMed Google Scholar
• Le AD, Harding S, Juzytsch W, Fletcher PJ, Shaham Y (2002). The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J Neurosci 22: 7844–7849.
  Article CAS PubMed PubMed Central Google Scholar
• Lee S, Rivier C (1997). An initial, three-day-long treatment with alcohol induces a long-lasting phenomenon of selective tolerance in the activity of the rat hypothalamic-pituitary-adrenal axis. J Neurosci 17: 8856–8866.
  Article CAS PubMed PubMed Central Google Scholar
• Ling PM, Neilands TB, Glantz SA (2009). Young adult smoking behavior: a national survey. Am J Prev Med 36: 389–394 e2.
  Article PubMed PubMed Central Google Scholar
• Liu X, Weiss F (2002). Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci 22: 7856–7861.
  Article CAS PubMed PubMed Central Google Scholar
• Lodge DJ, Lawrence AJ (2003). The CRF1 receptor antagonist antalarmin reduces volitional ethanol consumption in isolation-reared fawn-hooded rats. Neuroscience 117: 243–247.
  Article CAS PubMed Google Scholar
• Loh DH, Abad C, Colwell CS, Waschek JA (2008). Vasoactive intestinal peptide is critical for circadian regulation of glucocorticoids. Neuroendocrinology 88: 246–255.
  Article CAS PubMed Google Scholar
• Lowery EG, Sparrow AM, Breese GR, Knapp DJ, Thiele TE (2008). The CRF-1 receptor antagonist, CP-154,526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice. Alcohol Clin Exp Res 32: 240–248.
  Article CAS PubMed Google Scholar
• Lyons AM, Lowery EG, Sparta DR, Thiele TE (2008). Effects of food availability and administration of orexigenic and anorectic agents on elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res 32: 1962–1968.
  CAS PubMed PubMed Central Google Scholar
• Matsuzaki I, Takamatsu Y, Moroji T (1989). The effects of intracerebroventricularly injected corticotropin-releasing factor (CRF) on the central nervous system: behavioural and biochemical studies. Neuropeptides 13: 147–155.
  Article CAS PubMed Google Scholar
• Menzaghi F, Rassnick S, Heinrichs S, Baldwin H, Pich EM, Weiss F et al (1994). The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal. Ann N Y Acad Sci 739: 176–184.
  Article CAS PubMed Google Scholar
• Merlo Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF et al (1995). Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15: 5439–5447.
  Article CAS PubMed Google Scholar
• Morrow AL, Porcu P, Boyd KN, Grant KA (2006). Hypothalamic-pituitary-adrenal axis modulation of GABAergic neuroactive steroids influences ethanol sensitivity and drinking behavior. Dialogues in Clinical Neuroscience 8: 463–477.
  PubMed PubMed Central Google Scholar
• Nair A, Bonneau RH (2006). Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. Journal of Neuroimmunology 171: 72–85.
  Article CAS PubMed Google Scholar
• National Institute on Alcohol and Alcoholism Advisory Council (2004). NIAAA council approves definition of binge drinking. In NIAAA Newsletter, Vol. Winter.
• Navarro M, Cubero I, Chen AS, Chen HY, Knapp DJ, Breese GR et al (2005). Effects of melanocortin receptor activation and blockade on ethanol intake: A possible role for the melanocortin-4 receptor. Alcohol Clin Exp Res 29: 949–957.
  Article CAS PubMed PubMed Central Google Scholar
• Nelson DE, Naimi TS, Brewer RD, Nelson HA (2009). State alcohol-use estimates among youth and adults, 1993–2005. Am J Prev Med 36: 218–224.
  Article PubMed Google Scholar
• Nishikawa H, Hata T, Itoh E, Funakami Y (2004). A role for corticotropin-releasing factor in repeated cold stress-induced anxiety-like behavior during forced swimming and elevated plus-maze tests in mice. Biol Pharm Bull 27: 352–356.
  Article CAS PubMed Google Scholar
• O'Callaghan MJ, Croft AP, Jacquot C, Little HJ (2005). The hypothalamopituitary-adrenal axis and alcohol preference. Brain Res Bull 68: 171–178.
  Article CAS PubMed Google Scholar
• Ogilvie K, Lee S, Rivier C (1997). Effect of three different modes of alcohol administration on the activity of the rat hypothalamic-pituitary-adrenal axis. Alcohol Clin Exp Res 21: 467–476.
  Article CAS PubMed Google Scholar
• Olive MF, Koenig HN, Nannini MA, Hodge CW (2002). Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol Biochem Behav 72: 213–220.
  Article CAS PubMed Google Scholar
• Overstreet DH, Knapp DJ, Breese GR (2007). Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats. Alcohol Clin Exp Res 31: 1473–1481.
  Article CAS PubMed PubMed Central Google Scholar
• Peeters BW, Tonnaer JA, Groen MB, Broekkamp CL, van der Voort HA, Schoonen WG et al (2004). Glucocorticoid receptor antagonists: new tools to investigate disorders characterizedby cortisol hypersecretion. Stress (Amsterdam, Netherlands) 7: 233–241.
  Article CAS Google Scholar
• Piazza PV, Maccari S, Deminiere JM, Le Moal M, Mormede P, Simon H (1991). Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci USA 88: 2088–2092.
  Article CAS PubMed PubMed Central Google Scholar
• Pich EM, Lorang M, Yeganeh M, Rodriguez dF, Raber J, Koob GF et al (1995). Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15: 5439–5447.
  Article CAS PubMed Central Google Scholar
• Pioszak AA, Parker NR, Suino-Powell K, Xu HE (2008). Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1. J Biol Chem 283: 32900–32912.
  Article CAS PubMed PubMed Central Google Scholar
• Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K et al (1994). Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 91: 8777–8781.
  Article CAS PubMed PubMed Central Google Scholar
• Rassnick S, Heinrichs SC, Britton KT, Koob GF (1993). Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 605: 25–32.
  Article CAS PubMed Google Scholar
• Rhodes JS, Best K, Belknap JK, Finn DA, Crabbe JC (2005). Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol Behav 84: 53–63.
  Article CAS PubMed Google Scholar
• Rhodes JS, Ford MM, Yu CH, Brown LL, Finn DA, Garland Jr T et al (2007). Mouse inbred strain differences in ethanol drinking to intoxication. Genes Brain Behav 6: 1–18.
  Article CAS PubMed Google Scholar
• Richardson HN, Lee SY, O'Dell LE, Koob GF, Rivier CL (2008). Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur J Neurosci 28: 1641–1653.
  Article PubMed PubMed Central Google Scholar
• Rivier J, Rivier C, Vale W (1984). Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. Science (New York, NY) 224: 889–891.
  Article CAS Google Scholar
• Roberts AJ, Lessov CN, Phillips TJ (1995). Critical role for glucocorticoid receptors in stress- and ethanol-induced locomotor sensitization. J Pharmacol Exp Ther 275: 790–797.
  CAS PubMed Google Scholar
• Ryabinin AE, Bachtell RK, Heinrichs SC, Lee S, Rivier C, Olive MF et al (2002). The corticotropin-releasing factor/urocortin system and alcohol. Alcohol Clin Exp Res 26: 714–722.
  Article CAS PubMed Google Scholar
• Ryabinin AE, Weitemier AZ (2006). The urocortin 1 neurocircuit: ethanol-sensitivity and potential involvement in alcohol consumption. Brain Res Rev 52: 368–380.
  Article CAS PubMed Google Scholar
• Ryabinin AE, Yoneyama N, Tanchuck MA, Mark GP, Finn DA (2008). Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumption. Neuroscience 151: 780–790.
  Article CAS PubMed Google Scholar
• Salling MC, Faccidomo S, Hodge CW (2008). Nonselective suppression of operant ethanol and sucrose self-administration by the mGluR7 positive allosteric modulator AMN082. Pharmacol Biochem Behav 91: 14–20.
  Article CAS PubMed PubMed Central Google Scholar
• Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M et al (1996). CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. PNAS 93: 10477–10482.
  Article CAS PubMed PubMed Central Google Scholar
• Seidenstadt RM, Eaton KE (1978). Adrenal and ovarian regulation of salt and sucrose consumption. Physiol Behav 21: 313–316.
  Article CAS PubMed Google Scholar
• Shaham Y, Funk D, Erb S, Brown TJ, Walker CD, Stewart J (1997). Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci 17: 2605–2614.
  Article CAS PubMed PubMed Central Google Scholar
• Smart D, Coppell A, Rossant C, Hall M, McKnight AT (1999). Characterisation using microphysiometry of CRF receptor pharmacology. Eur J Pharmacol 379: 229–235.
  Article CAS PubMed Google Scholar
• Smith SM, Vale WW (2006). The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues in Clinical Neuroscience 8: 383–395.
  PubMed PubMed Central Google Scholar
• Sommer WH, Rimondini R, Hansson AC, Hipskind PA, Gehlert DR, Barr CS et al (2008). Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala Crhr1 expression following a history of dependence. Biol Psychiatry 63: 139–145.
  Article PubMed Google Scholar
• Song C, Earley B, Leonard BE (1995). Behavioral, neurochemical, and immunological responses to CRF administration. Is CRF a mediator of stress? Ann N Y Acad Sci 771: 55–72.
  Article CAS PubMed Google Scholar
• Song C, Earley B, Leonard BE (1997). Effect of chronic pretreatment with the sigma ligand JO 1784 on CRF-induced changes in behaviour, neurotransmitter and immunological function in the rat. Neuropsychobiology 35: 200–204.
  Article CAS PubMed Google Scholar
• Sparta DR, Ferraro III FM, Fee JR, Knapp DJ, Breese GR, Thiele TE (2009). The alcohol deprivation effect in C57BL/6J mice is observed using operant self-administration procedures and is modulated by CRF-1 receptor signaling. Alcohol Clin Exp Res 33: 31–42.
  Article CAS PubMed Google Scholar
• Sparta DR, Sparrow AM, Lowery EG, Fee JR, Knapp DJ, Thiele TE (2008). Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res 32: 259–265.
  Article CAS PubMed Google Scholar
• Sundell L, Salomaa V, Vartiainen E, Poikolainen K, Laatikainen T (2008). Increased stroke risk is related to a binge-drinking habit. Stroke 39: 3179–3184.
  Article PubMed Google Scholar
• Szumlinski KK, Diab ME, Friedman R, Henze LM, Lominac KD, Bowers MS (2007). Accumbens neurochemical adaptations produced by binge-like alcohol consumption. Psychopharmacology (Berl) 190: 415–431.
  Article CAS Google Scholar
• Terawaki K, Koike K, Yuzurihara M, Kase Y, Takeda S, Aburada M et al (2004). Effects of the traditional Japanese medicine Unkei-to on the corticotropin-releasing factor-induced increase in locomotor activity. Pharmacol Biochem Behav 78: 799–803.
  Article CAS PubMed Google Scholar
• Toriola AT, Kurl S, Laukkanen JA, Kauhanen J (2009). Does binge drinking increase the risk of lung cancer: results from the Findrink study. Eur J Public Health 19: 389–393.
  Article PubMed Google Scholar
• Treutlein J, Kissling C, Frank J, Wiemann S, Dong L, Depner M et al (2006). Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry 11: 594–602.
  Article CAS PubMed Google Scholar
• Valdez GR, Koob GF (2004). Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol Biochem Behav 79: 671–689.
  Article CAS PubMed Google Scholar
• Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP et al (2002). Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res 26: 1494–1501.
  Article CAS PubMed Google Scholar
• Veldhuis HD, De Wied D (1984). Differential behavioral actions of corticotropin-releasing factor (CRF). Pharmacol Biochem Behav 21: 707–713.
  Article CAS PubMed Google Scholar
• Venihaki M, Sakihara S, Subramanian S, Dikkes P, Weninger SC, Liapakis G et al (2004). Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behaviours. J Neuroendocrinol 16: 411–422.
  Article CAS PubMed Google Scholar
• Yang X, Wang S, Rice KC, Munro CA, Wand GS (2008). Restraint stress and ethanol consumption in two mouse strains. Alcohol Clin Exp Res 32: 840–852.
  Article CAS PubMed PubMed Central Google Scholar
• Zorrilla EP, Valdez GR, Weiss F (2001). Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl) 158: 374–381.
  Article CAS Google Scholar